As announced by MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) on 5 October 2018, MMJ's shareholders have approved the resolutions necessary for the disposal of PhytoTech Therapeutics Ltd to Harvest One Cannabis Inc (CVE:HVT).
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to invite shareholders to hear its CEO Jason Conroy present at Proactive Investors' CEO Spotlight Investor Session in Sydney on Monday, 22 October 2018. MMJ will be one of five companies presenting on the day and a light lunch will be provided.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a release from MediPharm Labs Inc (TSX-V: LABS) announcing that it has entered into a Cannabis Concentrate Program Agreement with Emerald Health Therapeutics Inc (CVE:EMH).
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a release from MediPharm Labs Inc. (TSX-V: LABS) providing a corporate update highlighting their achievements and ongoing activities.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is delighted to note that MediPharm Labs Inc. (TSX-V: LABS) made a strong debut overnight on the TSX Venture Exchange with its shares closing at CAD$2.29, 169% above MMJ's entry cost.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to confirm that the General Meeting of Shareholders scheduled for 2pm (AEST) today will proceed as planned.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the interview given yesterday by its CEO, Jason Conroy, to Proactive Investors Sydney.
